Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACLY | P53396 | 1/20 | 0.63 |
| ▸ | ACACB | O00763 | 1/20 | 0.61 |
| ▸ | ACACA | Q13085 | 1/20 | 0.61 |
| ▸ | CES2 | O00748 | 1/20 | 0.47 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.46 |
| ▸ | PPARG | P37231 | 6/20 | 0.46 |
| ▸ | PPARD | Q03181 | 6/20 | 0.46 |
| ▸ | PPARA | Q07869 | 6/20 | 0.46 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.46 |
| ▸ | TSHR | P16473 | 4/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | TLR2 | O60603 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | FABP4 | P15090 | 2/20 | 0.46 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.46 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.46 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | ESR1 | P03372 | 1/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3161067 | 1.00 | ACLY (0.63) | ACLYACACBACACACES2GPR84 | |
| SCHEMBL5878872 | 1.00 | ACLY (0.63) | ACLYACACBACACACES2GPR84 | |
| SCHEMBL607570 | 1.00 | ACLY (0.63) | ACLYACACBACACACES2GPR84 | |
| SCHEMBL892280 | 1.00 | ACLY (0.63) | ACLYACACBACACACES2GPR84 | |
| SCHEMBL2182533 | 1.00 | ACLY (0.63) | ACLYACACBACACACES2GPR84 | |
| SCHEMBL1716734 | 1.00 | ACLY (0.63) | ACLYACACBACACACES2GPR84 | |
| SCHEMBL11048015 | 1.00 | ACLY (0.63) | ACLYACACBACACACES2GPR84 | |
| SCHEMBL11047324 | 1.00 | ACLY (0.63) | ACLYACACBACACACES2GPR84 | |
| SCHEMBL284791 | 1.00 | ACLY (0.63) | ACLYACACBACACACES2GPR84 | |
| SCHEMBL11327336 | 1.00 | ACLY (0.63) | ACLYACACBACACACES2GPR84 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 232 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116789694-A | Use of tris (trimethylsilyl) borate as hydroxyl, carboxyl and amino, and amide protecting agent | 衢州科峰新材料有限公司 | 2023-09-22 | — | — | CN | claimed |
| WO-2023116088-A1 | THERMOCHROMISM INDICATOR | 江苏集萃智能液晶科技有限公司 | 2023-06-29 | — | — | WO | claimed |
| CN-113258134-B | Organic phase-change electrolyte and application thereof | 北京航空航天大学 | 2022-11-11 | — | — | CN | claimed |
| CN-114353991-A | Temperature-sensitive color-changing indicator | 江苏集萃智能液晶科技有限公司 | 2022-04-15 | — | — | CN | claimed |
| CN-113258134-A | Organic phase-change electrolyte and application thereof | 北京航空航天大学 | 2021-08-13 | — | — | CN | claimed |
| CN-113015443-A | Aerosol generation | 尼科创业贸易有限公司 | 2021-06-22 | — | — | CN | claimed |
| CN-112955032-A | Aerosol-generating substrate | 尼科创业贸易有限公司 | 2021-06-11 | — | — | CN | claimed |
| CN-111574888-A | Thermochromic material, preparation method thereof and thermochromic microcapsule containing thermochromic material | 武汉中科先进技术研究院有限公司 | 2020-08-25 | — | — | CN | claimed |
| US-9956201-B2 | Compositions comprising bioreversible derivatives of hydroxy N-substituted-2-aminotetralins, and related dosage forms | SPRIASO LLC (US) | 2018-05-01 | — | — | US | claimed |
| EP-2644185-B1 | THICK CLEANING COMPOSITION | SUZHOU ELECO CHEMICAL IND CO LTD (CN) | 2018-04-25 | — | — | EP | claimed |
| CN-1414848-A | Prevention of plaque rupture by ACAT inhibitors | WARNER LAMBERT CO (US) | 2003-04-30 | — | — | CN | claimed |
| JP-2003513909-A | — | — | 2003-04-15 | — | — | JP | claimed |
| EP-1229907-A1 | PREVENTION OF PLAQUE RUPTURE BY ACAT INHIBITORS | WARNER-LAMBERT COMPANY (US) | 2002-08-14 | — | — | EP | claimed |
| JP-2001520304-A | — | — | 2001-10-30 | — | — | JP | claimed |
| CN-1310629-A | Combined administration of ACAT and MMP inhibitors for the treatment of atherosclerotic lesions | WARNER LAMBERT CO (US) | 2001-08-29 | — | — | CN | claimed |
| WO-2001034127-A1 | PREVENTION OF PLAQUE RUPTURE BY ACAT INHIBITORS | WARNER-LAMBERT COMPANY (US) | 2001-05-17 | — | — | WO | claimed |
| EP-1098662-A2 | COADMINISTRATION OF ACAT AND MMP INHIBITORS FOR THE TREATMENT OF ATHEROSCLEROTIC LESIONS | WARNER-LAMBERT COMPANY (US) | 2001-05-16 | — | — | EP | claimed |
| EP-1025190-A2 | FATTY ACIDS, SOAPS, SURFACTANT SYSTEMS, AND CONSUMER PRODUCTS BASED THEREON | THE PROCTER & GAMBLE COMPANY (US) | 2000-08-09 | — | — | EP | claimed |
| WO-2000004892-A2 | COADMINISTRATION OF ACAT AND MMP INHIBITORS FOR THE TREATMENT OF ATHEROSCLEROTIC LESIONS | WARNER-LAMBERT COMPANY (US) | 2000-02-03 | — | — | WO | claimed |
| WO-1999020722-A2 | FATTY ACIDS, SOAPS, SURFACTANT SYSTEMS, AND CONSUMER PRODUCTS BASED THEREON | THE PROCTER & GAMBLE COMPANY (US) | 1999-04-29 | — | — | WO | claimed |